| 摘要 |
<p>TGR5 (a.k.a. GPBAR1) agonists of structural formula l(Q), (Formula I(Q)) wherein X, R1, R2, and R5 are defined in the specification, pharmaceutically acceptable salts thereof, compositions thereof, and use of the compounds and compositions for treating diseases in which TGR5 is a mediator or is implicated. The invention also comprises use of the compounds in and for the manufacture of medicaments, particularly for treating diseases in which TGR5 is a mediator or is implicated.</p> |
